Market Overview

Neurocrine Biosciences, Inc. (NASDAQ: NBIX)

101.65 -0.22 (-0.22%)

Analyst Ratings

DateResearch FirmActionCurrentPT
8/04/20Canaccord GenuityMaintainsBuy145.0
8/04/20Credit SuisseMaintainsNeutral126.0
8/04/20Morgan StanleyMaintainsOverweight146.0
8/04/20MizuhoMaintainsNeutral132.0
8/04/20Cantor FitzgeraldMaintainsOverweight161.0
8/04/20HC Wainwright & Co.MaintainsBuy140.0
8/04/20JP MorganDowngradesNeutral136.0
8/04/20SVB LeerinkMaintainsMarket Perform120.0
7/23/20MizuhoMaintainsNeutral127.0
7/20/20Credit SuisseMaintainsNeutral135.0

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!

Sign up to receive Benzinga's Daily Ratings Newsletter